Caricamento...
Biological therapies for atrial fibrillation: ready for prime time?
Atrial fibrillation is a prominent cause of morbidity and mortality in developed countries. Treatment strategies center on controlling atrial rhythm or ventricular rate. The need for anticoagulation is an independent decision from the rate vs. rhythm control debate. This review discusses novel biolo...
Salvato in:
| Pubblicato in: | J Cardiovasc Pharmacol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879872/ https://ncbi.nlm.nih.gov/pubmed/26222989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000293 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|